Literature DB >> 19962666

Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.

Darren J Baker1, Fang Jin, Karthik B Jeganathan, Jan M van Deursen.   

Abstract

Genetic alterations that promote chromosome missegregation have been proposed to drive tumorigenesis through loss of whole chromosomes containing key tumor suppressor genes. To test this unproven idea, we bred Bub1 mutant mice that inaccurately segregate their chromosomes onto p53(+/-), Apc(Min/+), Rb(+/-), or Pten(+/-) backgrounds. Bub1 insufficiency predisposed p53(+/-) mice to thymic lymphomas and Apc(Min/+) mice to colonic tumors. These tumors consistently lacked the nonmutated tumor suppressor allele but had gained a copy of the mutant allele. In contrast, Bub1 insufficiency had no impact on tumorigenesis in Rb(+/-) mice and inhibited prostatic intraepithelial neoplasia formation in Pten(+/-) mice. Thus, Bub1 insufficiency can drive tumor formation through tumor suppressor gene loss of heterozygosity, but only in restricted genetic and cellular contexts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962666      PMCID: PMC2842992          DOI: 10.1016/j.ccr.2009.10.023

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  44 in total

Review 1.  Aneuploidy: cells losing their balance.

Authors:  Eduardo M Torres; Bret R Williams; Angelika Amon
Journal:  Genetics       Date:  2008-06       Impact factor: 4.562

2.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

3.  Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.

Authors:  Masayoshi Shichiri; Keigo Yoshinaga; Hisashi Hisatomi; Kenichi Sugihara; Yukio Hirata
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

4.  Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice.

Authors:  Paul Kalitsis; Kerry J Fowler; Belinda Griffiths; Elizabeth Earle; C W Chow; Kris Jamsen; K H Andy Choo
Journal:  Genes Chromosomes Cancer       Date:  2005-09       Impact factor: 5.006

Review 5.  The kinetochore and cancer: what's the connection?

Authors:  Karen W Y Yuen; Ben Montpetit; Philip Hieter
Journal:  Curr Opin Cell Biol       Date:  2005-10-17       Impact factor: 8.382

6.  The retinoblastoma protein regulates pericentric heterochromatin.

Authors:  Christian E Isaac; Sarah M Francis; Alison L Martens; Lisa M Julian; Laurie A Seifried; Natalie Erdmann; Ulrich K Binné; Lea Harrington; Piotr Sicinski; Nathalie G Bérubé; Nicholas J Dyson; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

7.  Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.

Authors:  C A Hawkins; E J Bergstralh; M M Lieber; H Zincke
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

8.  Dosage sensitivity and the evolution of gene families in yeast.

Authors:  Balázs Papp; Csaba Pál; Laurence D Hurst
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

Review 9.  Aneuploidy: instigator and inhibitor of tumorigenesis.

Authors:  Beth A A Weaver; Don W Cleveland
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

10.  Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.

Authors:  Geert J P L Kops; Daniel R Foltz; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

View more
  117 in total

Review 1.  Measuring genome instability in aging - a mini-review.

Authors:  Wenge Li; Jan Vijg
Journal:  Gerontology       Date:  2011-12-10       Impact factor: 5.140

Review 2.  Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.

Authors:  A Ogden; P C G Rida; R Aneja
Journal:  Cell Death Differ       Date:  2012-06-01       Impact factor: 15.828

Review 3.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

4.  Centrosome-related genes, genetic variation, and risk of breast cancer.

Authors:  J E Olson; X Wang; V S Pankratz; Z S Fredericksen; C M Vachon; R A Vierkant; J R Cerhan; F J Couch
Journal:  Breast Cancer Res Treat       Date:  2010-05-28       Impact factor: 4.872

Review 5.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

Review 6.  RB: mitotic implications of a tumour suppressor.

Authors:  Amity L Manning; Nicholas J Dyson
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

7.  Cyclin B2 and p53 control proper timing of centrosome separation.

Authors:  Hyun-Ja Nam; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2014-04-28       Impact factor: 28.824

8.  A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis.

Authors:  Jason M Sheltzer
Journal:  Cancer Res       Date:  2013-09-16       Impact factor: 12.701

9.  Very CIN-ful: whole chromosome instability promotes tumor suppressor loss of heterozygosity.

Authors:  Rocio Sotillo; Juan-Manuel Schvartzman; Robert Benezra
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

10.  An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.

Authors:  Andrew C Nelson; Nischalan Pillay; Stephen Henderson; Nadège Presneau; Roberto Tirabosco; Dina Halai; Fitim Berisha; Paul Flicek; Derek L Stemple; Claudio D Stern; Fiona C Wardle; Adrienne M Flanagan
Journal:  J Pathol       Date:  2012-09-26       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.